Hormonal and metabolic effects of morning or evening dosing of the dipeptidyl peptidase IV inhibitor vildagliptin in patients with type 2 diabetes

MLA

Yan-Ling, He, et al. “Hormonal and Metabolic Effects of Morning or Evening Dosing of the Dipeptidyl Peptidase IV Inhibitor Vildagliptin in Patients with Type 2 Diabetes.” British Journal of Clinical Pharmacology, vol. 70, no. 1, July 2010. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........3ac6753661937a37f6147a0ec3dffe3d&authtype=sso&custid=ns315887.

APA

Yan-Ling, H., Jessica, V., Yiming, Z., Sherwyn L, S., Monica, L.-S., James, F., & William P, D. (2010). Hormonal and metabolic effects of morning or evening dosing of the dipeptidyl peptidase IV inhibitor vildagliptin in patients with type 2 diabetes. British Journal of Clinical Pharmacology, 70(1).

Chicago

Yan-Ling, He, Valencia Jessica, Zhang Yiming, Schwartz Sherwyn L, Ligueros-Saylan Monica, Foley James, and Dole William P. 2010. “Hormonal and Metabolic Effects of Morning or Evening Dosing of the Dipeptidyl Peptidase IV Inhibitor Vildagliptin in Patients with Type 2 Diabetes.” British Journal of Clinical Pharmacology 70 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........3ac6753661937a37f6147a0ec3dffe3d&authtype=sso&custid=ns315887.